MRK

#42
Merck & Company, Inc. Common Stock
118.7 9 USD
-0.69%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
118.79
120.67
년간 변동
75.40
125.14
일일 변동
-0.69%
월간 변동
+8.01%
6달 변화
+13.60%
년간 변동율
+54.39%
이전 종가
119.6 2
Open
119.7 6
저가
118.7 9
High
120.6 7
양
955
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 293.39 B
  • Employee 75 K
  • Founded N/A
  • CEO Robert M Davis
  • Website www.merck.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BPD168
  • Industry 종합 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
14.46
주가매출액비율
4.06
주당 배당금
3.28
배당수익률 %
3.12

Merck & Company, Inc. Common Stock

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

뉴스